Hemophilia A future or investigational therapies

Hemophilia A Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hemophilia A from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hemophilia A future or investigational therapies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hemophilia A future or investigational therapies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hemophilia A future or investigational therapies
CDC on Hemophilia A future or investigational therapies
Hemophilia A future or investigational therapies in the news
Blogs on Hemophilia A future or investigational therapies
Directions to Hospitals Treating Hemophilia A
Risk calculators and risk factors for Hemophilia A future or investigational therapies

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Research is underway regarding gene therapy to correct the chromosomal deficit which results in Hemophilia A. Currently, there is no role for gene therapy in the management of hemophilia A, though the issue is actively being studied in clinical trials